Hair Anew

Australia - English - Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:
ascorbic acid,Bambusa breviflora,Biotin,calcium pantothenate,d-alpha-tocopheryl acid succinate,Ginkgo biloba,inositol,Kelp Powder,nicotinamide,pyridoxine hydrochloride,zinc gluconate
Available from:
Naturenetics Australia Pty Ltd
Authorization status:
Authorization number:

Public Summary

Summary for ARTG Entry:


Hair Anew

ARTG entry for

Medicine Listed


Naturenetics Australia Pty Ltd

Postal Address

7 Regatta Avenue,Caringbah South, NSW, 2229


ARTG Start Date


Product category




Approval area

Listed Medicines


Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be


The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

The Ginkgo biloba leaf extract used in the manufacture of this medicine must comply with the requirement of Identification Test B of the monograph

Powdered Ginkgo Extract in the United States Pharmacopeia 32 - National Formulary 27 (USP32-NF27) as in force or existing from time to time. This

condition does not apply to powdered or dried leaf.


1. Hair Anew

Product Type

Single Medicine Product

Effective date


Permitted Indications

Aid/assist/help/maintain healthy hair follicles

Maintain/support hair growth

Enhance/improve/promote/increase hair growth

Maintain/support hair health

Enhance/improve/promote/increase hair health

Indication Requirements

No Indication Requirements included on Record

Standard Indications

No Standard Indications included on Record

Specific Indications


Children, pregnant or breastfeeding women, and those who have recently had a heart attack, surgery or a major accident should not consume this

product without medical advice (or words to that effect) [in 1.5 mm type].

Additional Product information

Pack Size/Poison information

Public Summary

Page 1 of

Produced at 29.09.2019 at 05:54:59 AEST

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information

Pack Size

Poison Schedule


1. Formulation 1

Dosage Form

Capsule, hard

Route of Administration


Visual Identification

Active Ingredients

ascorbic acid

375 mg

Bambusa breviflora

14 mg

Equivalent: Bambusa breviflora (Dry)

140 mg


2.5 mg

calcium pantothenate

21.83 mg

d-alpha-tocopheryl acid succinate

20.67 mg

Ginkgo biloba

22.5 mg

Equivalent: Ginkgo biloba (Dry)

1.125 g


25 mg

Kelp Powder

80 mg


12.5 mg

pyridoxine hydrochloride

12.5 mg

zinc gluconate

39.06 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at

Public Summary

Page 2 of

Produced at 29.09.2019 at 05:54:59 AEST

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information

Similar products

Search alerts related to this product

Share this information